The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
Top Cited Papers
- 13 October 2009
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 54 (17), 1609-1616
- https://doi.org/10.1016/j.jacc.2009.04.053
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Von Willebrand Factor, Type 2 Diabetes Mellitus, and Risk of Cardiovascular DiseaseCirculation, 2008
- Pharmacogenetic Predictors of Statin-Mediated Low-Density Lipoprotein Cholesterol Reduction and Dose ResponseCirculation: Cardiovascular Genetics, 2008
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide StudyNew England Journal of Medicine, 2008
- Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery diseaseAmerican Heart Journal, 2008
- CYP2D6*4 polymorphism is associated with statin-induced muscle effectsPharmacogenetics and Genomics, 2007
- Statin Safety: An Assessment Using an Administrative Claims DatabaseThe American Journal of Cardiology, 2006
- Statins, Cardiovascular Disease, and Drug SafetyThe American Journal of Cardiology, 2006
- Statin Safety: An Overview and Assessment of the Data—2005The American Journal of Cardiology, 2006
- An Assessment of Statin Safety by Muscle ExpertsThe American Journal of Cardiology, 2006
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004